Skip to main content
. 2019 Jul 4;85(6):E1084–E1094. doi: 10.1093/neuros/nyz229

TABLE 4.

Univariable and Multivariable Cox Regression for Radiographic Progression-Free Survival Following Definitive GKRS for Vestibular Schwannomas

Covariate Univariable regression Multivariable regression
HR (95% CI) P value HR (95% CI) P value
Age 1.010 (0.970-1.052) .634 N/A
Gender
 Male Reference N/A
 Female 1.478 (0.593-3.682) .401 N/A
Laterality
 Left Reference N/A
 Right 1.036 (0.415-2.583) .940 N/A
Year of diagnosis 1.009 (0.885-1.150) .896 N/A
Pretreatment serviceable hearing
 Yes (Gardner-Robertson I or II) Reference N/A
 No (Gardner-Robertson III, IV, or V) 1.003 (0.311-3.234) .997 N/A
Pretreatment hearing loss
 Yes 1.026 (0.231-4.563) .973 N/A
 No Reference
Pretreatment CN VII dysfunction
 Yes 0.044 (0.000-97.313) .426 N/A
 No Reference
Pretreatment CN V dysfunction
 Yes 1.266 (0.289-5.548) .754 N/A
 No Reference
Tumor size, max. diameter 0.623 (0.253-1.533) .303 N/A
Tumor size, volume 0.790 (0.381-1.635) .525 N/A
Tumor grade (Samii classification) 1.069 (0.801-1.427) .651 N/A
Dose rate, median
  < 2.675 Gy/min Reference
  ≥ 2.675 Gy/min 1.300 (0.518-3.265) .576 N/A
Dose rate, continuous 1.424 (0.716-2.834) .314 N/A
Prescription isodose 0.998 (0.953-1.045) .926 N/A
Mean target dose (Gy) 1.001 (0.912-1.097) .991 N/A
Minimum target dose (Gy) 0.950 (0.762-1.184) .646 N/A
Maximum target dose (Gy) 0.991 (0.913-1.076) .838 N/A
RTOG conformity index 0.908 (0.277-2.983) .874 N/A
Paddick conformity index 3.279 (0.023-469.685) .639 N/A
Selectivity index 3.416 (0.031-377.991) .609 N/A
Energy index 9.072 (0.317-259.60) .198 N/A
RTOG homogeneity index 0.748 (0.036-15.373) .850 N/A